Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PRASFIT-Elective Study: PRASugrel Compared to Clopidogrel For Japanese PatIenTs with Coronary Artery Disease Undergoing Elective PCI

Next Previous
X
Search
Trial Profile

PRASFIT-Elective Study: PRASugrel Compared to Clopidogrel For Japanese PatIenTs with Coronary Artery Disease Undergoing Elective PCI

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 Jan 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Prasugrel (Primary) ; Aspirin; Clopidogrel
  • Indications Angina pectoris; Coronary artery disease; Embolism and thrombosis; Myocardial infarction
  • Focus Registrational; Therapeutic Use
  • Acronyms PRASFIT-Elective
  • Sponsors Daiichi Sankyo Company; Ube Industries

    • Most Recent Events

    • 28 Dec 2020 Results of meta-analysis comparing safety and efficacy of pP2Y12-I versus Clopidogrel in patients with CAD undergoing elective PCI published in the American Journal of Cardiology
    • 24 Mar 2014 The Ministry of Health, Labour and Welfare in Japan has approved prasugrel in patients undergoing PCI based on results from this trial and and the PRASFIT-Elective trial according to a Daiichi Sankyo Company media release.
    • 12 Jul 2013 Primary endpoint 'Cardiovascular-event-rate' has been met, according resutls reported in a Daiichi Sankyo Company media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top